Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Sales | 691,000 | 726,000 | 708,000 | 716,689 | 575,390 |
| Cost of Goods | 283,000 | 235,000 | 230,000 | 243,210 | 200,450 |
| Gross Profit | 408,000 | 491,000 | 478,000 | 439,260 | 374,930 |
| Operating Expenses | 291,000 | 289,000 | 289,000 | 324,370 | 255,370 |
| Operating Income | 117,000 | 202,000 | 189,000 | 149,319 | 120,020 |
| Interest Expense | 26,000 | 35,000 | 35,000 | 37,640 | 15,690 |
| Other Income | -7,000 | -2,000 | -3,000 | 37,021 | -750,520 |
| Pre-tax Income | 84,000 | 165,000 | 151,000 | 148,700 | -646,190 |
| Income Tax | 29,000 | 56,000 | 51,000 | 49,310 | -136,790 |
| Net Income Continuous | 55,000 | 109,000 | 100,000 | 70,458 | -461,928 |
| Net Income | $55,000 | $109,000 | $100,000 | $70,458 | $-461,928 |
| EPS Basic Total Ops | 0.07 | 0.14 | 0.13 | 0.09 | -0.65 |
| EPS Basic Continuous Ops | 0.07 | 0.13 | 0.13 | 0.09 | -0.59 |
| EPS Diluted Total Ops | 0.07 | 0.14 | 0.13 | 0.09 | -0.59 |
| EPS Diluted Continuous Ops | 0.07 | 0.13 | 0.12 | 0.09 | -0.59 |
| EBITDA(a) | $117,000 | $202,000 | $189,000 | $277,919 | $120,020 |